Loading stock data…
$4.08-0.08 (-2.00%)
Jaguar Health, Inc., a commercial-stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress.
Jaguar Health, Inc. in the Healthcare sector is trading at $4.08 with a market capitalization of $1M. The stock is currently near its 52-week low of $2.35, remaining 97.3% below its 200-day moving average. On fundamentals, Piotroski 3/9 flags weak fundamentals, Altman Z in the distress zone. The Whystock Score of 25/100 signals elevated caution as multiple indicators diverge.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $1.23M↓ | $20.25M↑ | $3.23M↑ | $3.08M↑ | $2.98M |
| Gross Profit | $194,000↓ | $19.09M↑ | $1.03M↓ | $2.55M↑ | $2.45M |
| Operating Income | -$7.60M↓ | $10.18M↑ | -$20.44M↓ | -$7.24M↑ | -$8.01M |
| Net Income | -$12.68M↓ | $8.85M↑ | -$23.06M↓ | -$9.50M↑ | -$10.41M |
Jaguar Health, Inc., a commercial-stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress. It operates through two segments, Animal Health and Human Health. The com...